Literature DB >> 31251970

Combination biologic therapy for severe persistent asthma.

Gilbert Ortega1, Pamela Tongchinsub2, Tara Carr2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31251970     DOI: 10.1016/j.anai.2019.06.013

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  6 in total

1.  Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases.

Authors:  Mitchell M Pitlick; Thanai Pongdee
Journal:  World Allergy Organ J       Date:  2022-10-13       Impact factor: 5.516

Review 2.  Precision medicine in severe pediatric asthma: opportunities and challenges.

Authors:  Susanne J H Vijverberg; Paul Brinkman; Niels W P Rutjes; Anke H Maitland-van der Zee
Journal:  Curr Opin Pulm Med       Date:  2020-01       Impact factor: 2.868

Review 3. 

Authors:  Andrea Bauer; Heinrich Dickel; Thilo Jakob; Andreas Kleinheinz; Undine Lippert; Martin Metz; Sibylle Schliemann; Uwe Schwichtenberg; Petra Staubach; Eva Valesky; Nicola Wagner; Bettina Wedi; Marcus Maurer
Journal:  Allergo J       Date:  2021-03-26

Review 4.  Specific Therapy for T2 Asthma.

Authors:  Diego Bagnasco; Elisa Testino; Stefania Nicola; Laura Melissari; Maria Russo; Rikki Frank Canevari; Luisa Brussino; Giovanni Passalacqua
Journal:  J Pers Med       Date:  2022-04-07

Review 5.  Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice.

Authors:  Konstantinos Porpodis; Ioanna Tsiouprou; Apostolos Apostolopoulos; Polyxeni Ntontsi; Evangelia Fouka; Despoina Papakosta; Harissios Vliagoftis; Kalliopi Domvri
Journal:  J Pers Med       Date:  2022-06-30

Review 6.  Severe Asthma and Biological Therapy: When, Which, and for Whom.

Authors:  Paola Rogliani; Luigino Calzetta; Maria Gabriella Matera; Rossella Laitano; Beatrice Ludovica Ritondo; Nicola A Hanania; Mario Cazzola
Journal:  Pulm Ther       Date:  2019-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.